Journal article
Plasma cortisol, brain Amyloid-β, and cognitive decline in preclinical Alzheimer’s disease: A 6-Year prospective cohort study
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, Vol.2(1), pp.45-52
2017
Abstract
Background
Hypothalamic-pituitary-adrenal axis dysregulation, which is typically assessed by measuring cortisol levels, is associated with cognitive dysfunction, hippocampal atrophy, and increased risk for mild cognitive impairment and Alzheimer’s disease (AD). However, little is known about the role of hypothalamic-pituitary-adrenal axis dysregulation in moderating the effect of high levels of amyloid-β (Aβ+) on cognitive decline in the preclinical phase of AD, which is often protracted, and thus offers opportunities for prevention and early intervention.
Methods
Using data from a 6-year multicenter prospective cohort study, we evaluated the relation between Aβ level, plasma cortisol level, and cognitive decline in 416 cognitively normal older adults.
Results
Results revealed that Aβ+ older adults experienced faster decline than Aβ− older adults in all cognitive domains (Cohen’s d at 6-year assessment = 0.37–0.65). They further indicated a significant interaction between Aβ and cortisol levels for global cognition (d = 0.32), episodic memory (d = 0.50), and executive function (d = 0.59) scores, with Aβ+ older adults with high cortisol levels having significantly faster decline in these domains compared with Aβ+ older adults with low cortisol levels. These effects were independent of age, sex, APOE genotype, anxiety symptoms, and radiotracer type.
Conclusions
In cognitively healthy older adults, Aβ+ is associated with greater cognitive decline and high plasma cortisol levels may accelerate the effect of Aβ+ on decline in global cognition, episodic memory, and executive function. These results suggest that therapies targeted toward lowering plasma cortisol and Aβ levels may be helpful in mitigating cognitive decline in the preclinical phase of AD.
Details
- Title
- Plasma cortisol, brain Amyloid-β, and cognitive decline in preclinical Alzheimer’s disease: A 6-Year prospective cohort study
- Authors/Creators
- R.H. Pietrzak (Author/Creator)S.M. Laws (Author/Creator)Y.Y. Lim (Author/Creator)S. J. Bender (Author/Creator)T. Porter (Author/Creator)J. Doecke (Author/Creator)D. Ames (Author/Creator)C. Fowler (Author/Creator)C.L. Masters (Author/Creator)L. Milicic (Author/Creator)S. Rainey-Smith (Author/Creator)V.L. Villemagne (Author/Creator)C.C. Rowe (Author/Creator)R.N. Martins (Author/Creator)P. Maruff (Author/Creator)
- Publication Details
- Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, Vol.2(1), pp.45-52
- Publisher
- Elsevier Inc. on behalf of Society of Biological Psychiatry
- Identifiers
- 991005544319607891
- Copyright
- © 2017 Elsevier Inc
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
28 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.5 Neuroscience
- 1.5.420 Stress and Cortisol
- Web Of Science research areas
- Neurosciences
- Psychiatry
- ESI research areas
- Neuroscience & Behavior